What does our growing understanding of the molecular subtypes of gastric and oesophageal cancers, and the results of recent trials testing multimodal therapies, mean for the way we classify, diagnose and treat these tumours? Jonas [more]
Suboptimal studies had established preoperative chemoradiation as the preferred strategy in the management of localised oesophageal cancer (LEC) and gastro-oesophageal cancer. The recent CROSS trial has now demonstrated considerable benefit from preoperative chemoradiation over surgery [more]
Robust evidence on the value of neoadjuvant chemotherapy, together with more effective imaging modalities, are opening up new options for gastro-oesophageal cancer. Download full article